{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:42:50Z","timestamp":1753180970015,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.trre.2025.100911","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T17:00:17Z","timestamp":1739811617000},"page":"100911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of everolimus administration on renal function in renal transplant recipients: A systematic review and dose\u2013response meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Takehiro","family":"Ohyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shodai","family":"Yoshihiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2025.100911_bb0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994-2004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0010","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.transproceed.2007.09.008","article-title":"Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy","volume":"39","author":"Chapman","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2025.100911_bb0015","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"year":"2011","series-title":"The 30th annual report of the Australia and New Zealand dialysis and transplant registry. Chapter 8: transplantation","author":"Clayton","key":"10.1016\/j.trre.2025.100911_bb0020"},{"key":"10.1016\/j.trre.2025.100911_bb0025","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1111\/j.1600-6143.2005.01100.x","article-title":"Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials","volume":"5","author":"Oberbauer","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0030","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2025.100911_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663602","article-title":"Conversion from calcineurin inhibitors to mammalian target of rapamycin inhibitors in kidney transplant recipients: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Zeng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2025.100911_bb0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.ftd.0000175911.70172.2e","article-title":"The role of therapeutic monitoring of everolimus in solid organ transplantation","volume":"27","author":"Mabasa","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2025.100911_bb0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"year":"2022","series-title":"Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022)","author":"Higgins","key":"10.1016\/j.trre.2025.100911_bb0050"},{"key":"10.1016\/j.trre.2025.100911_bb0055","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/0962280218773122","article-title":"One-stage dose\u2013response meta-analysis for aggregated data","volume":"28","author":"Crippa","year":"2019","journal-title":"Stat Methods Med Res"},{"year":"2020","series-title":"R: a language and environment for statistical computing","author":"R Core Team","key":"10.1016\/j.trre.2025.100911_bb0060"},{"key":"10.1016\/j.trre.2025.100911_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v072.c01","article-title":"Multivariate dose-response meta-analysis: the dosresmeta R package","volume":"72","author":"Crippa","year":"2016","journal-title":"J Stat Softw"},{"key":"10.1016\/j.trre.2025.100911_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.trre.2025.100911_bb0075","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/HJH.0b013e32830ef940","article-title":"Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients","volume":"26","author":"Seckinger","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.trre.2025.100911_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/TP.0b013e3181ac8cdd","article-title":"Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus","volume":"88","author":"Kihm","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100911_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","article-title":"Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial","volume":"377","author":"Budde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2025.100911_bb0090","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/j.1600-6143.2012.04162.x","article-title":"Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation","volume":"12","author":"Mj\u00f6rnstedt","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0095","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/ajt.13132","article-title":"Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA","volume":"15","author":"Rostaing","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0100","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/ndt\/gfx075","article-title":"Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from month 3: a multicentre, randomized trial","volume":"32","author":"Budde","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/2175-8239-jbn-3860","article-title":"Effect of conversion from calcineurin inhibitors to everolimus on hepatitis C viremia in adult kidney transplant recipients","volume":"40","author":"Pacheco","year":"2018","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.trre.2025.100911_bb0110","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20209369","article-title":"An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients","volume":"54","author":"Assis","year":"2021","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.trre.2025.100911_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13043","article-title":"Impact of early conversion from cyclosporin to everolimus on left ventricular mass index: a randomized controlled trial","volume":"31","author":"Krishnan","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0120","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ajt.14186","article-title":"Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: results of the randomized ELEVATE trial","volume":"17","author":"de Fijter","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100911_bb0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/tri.12252","article-title":"A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients","volume":"27","author":"Chadban","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2025.100911_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.trre.2015.09.001","article-title":"Everolimus immunosuppression in kidney transplantation: what is the optimal strategy?","volume":"30","author":"Witzke","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2025.100911_bb0135","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0041-1345(03)00607-9","article-title":"Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine","volume":"35","author":"Sol\u00e0","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2025.100911_bb0140","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1046\/j.1523-1755.2002.00668.x","article-title":"Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity","volume":"62","author":"Khanna","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2025.100911_bb0145","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1016\/j.transproceed.2005.09.178","article-title":"Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European multicentric study in kidney transplant patients","volume":"37","author":"Morales","year":"2005","journal-title":"Transplant Proc"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X25000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X25000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:37:13Z","timestamp":1747240633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X25000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0955470X25000114"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2025.100911","relation":{},"ISSN":["0955-470X"],"issn-type":[{"type":"print","value":"0955-470X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of everolimus administration on renal function in renal transplant recipients: A systematic review and dose\u2013response meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2025.100911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100911"}}